BHCM
PBH icon

Brevan Howard Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Brevan Howard Capital Management’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,390
Closed -$549K – 1968
2025
Q1 		$549K Buy
+6,390
New +$524K 0.01% 699

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Brevan Howard Capital Management's PBH Position: Q2 2025 in Review

Brevan Howard Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2025, closing a stake of 6,390 shares — an estimated $549K sold.

Brevan Howard Capital Management first reported a position in PBH in Q1 2025 and held it in 1 quarter. The position peaked at $549K in Q1 2025. 378 funds tracked by Wall St. Rank hold PBH as of Q2 2025.

  • Brevan Howard Capital Management reported no remaining Prestige Consumer Healthcare position as of Q2 2025 after selling out during the quarter.
  • Brevan Howard Capital Management sold 6,390 Prestige Consumer Healthcare shares in Q2 2025, an estimated $549K.
  • Brevan Howard Capital Management first reported a position in Prestige Consumer Healthcare in Q1 2025 and held it in 1 quarter.
  • Brevan Howard Capital Management's Prestige Consumer Healthcare position peaked at $549K in Q1 2025.
  • 378 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2025.

Based on Brevan Howard Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.